Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?

Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?

Severe acute respiratory syndrome coronavirus 2 (SARS coronavirus 2, or SARS-CoV-2) is the cause of the respiratory infection known as COVID-19. From an immunopathological standpoint, coronaviruses such as SARS-CoV-2 induce increased levels of a variety of T-helper 1 (Th1) and inflammatory cytokines...

Full description

Bibliographic Details
Main Authors: Stephen W. Mamber, Steven Krakowka, Jeffrey Osborn, Lloyd Saberski, Ryan G. Rhodes, Albert E. Dahlberg, Sunthorn Pond-Tor, Kara Fitzgerald, Neal Wright, Sarah Beseme, John McMichael
Format: Article
Language:English
Published: American Society for Microbiology 2020-05-01
Series:mSphere
Subjects:
covid-19
sars-cov-2
immunomodulatory agents
interferon alpha
phytocannabinoids
thimerosal
Online Access:https://doi.org/10.1128/mSphere.00288-20

Internet

https://doi.org/10.1128/mSphere.00288-20

Similar Items